ALMS

$9.90+1.02%website ↗

ALUMIS INC.

Market Cap

$1.2B

Sector

Materials

Industry

Pharmaceuticals

Beta

-0.21

5yr monthly vs SPY

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

16 analysts

Buy Activity

Buy Velocity Score

23.98x

Current Rate (90d)

8518.34/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

1

Sell Activity

Sell Velocity Score

28.33x

Sell Rate (90d)

1289.82/mo

Sell Baseline

0.00/mo

Unique Sellers (90d)

7

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-08	2026-09-09	AKKARAJU SRINIVAS	Director	Purchase	546.6K	$10.63	$5.81M	4.94M	View
2026-09-08	2026-09-09	AKKARAJU SRINIVAS	Director	Sale	96.1K	$10.55	$1.01M	2.03M	View
2026-09-04	2026-09-09	AKKARAJU SRINIVAS	Director	Purchase	220.1K	$11.17	$2.46M	4.71M	View
2026-08-03	2026-08-05	Bradley Mark Christopher	Chief Development Officer	Sale	2,572	$26.37	$68K	48.5K	View
2026-08-03	2026-08-05	Pangali Sanam	Chief Legal Officer	Sale	1,364	$26.37	$36K	9,747	View

1–5 of 10

1 / 2

Recent News

Alumis (ALMS) Plans to Advance Envudeucitinib After LUMUS Missed in the Overall Population

Yahoo · 2026-09-09

Gaming Realms CEO: Content growth accelerating as company expands into new markets

Yahoo Finance · 2026-09-08

Alumis Inc. (ALMS) Discusses Phase IIb LUMUS Trial Results and Subgroup Insights in Type 1 Interferon-Driven Diseases - Slideshow

SeekingAlpha · 2026-09-04

Alumis to Participate in Upcoming September Investor Conferences

Yahoo · 2026-09-04

Informational purposes only, not investment advice.